Cannabis, sport and anti-doping regulations with Tom Hudzik
In this episode Dr Rob Calder talks to Dr Thomas Hudzik about his work with the World Anti Doping Agency (WADA). Tom talks about the three principles by which a substance is assessed and how they use ...
21 Syys 202323min
Fentanyl, poly-substance use and the US opioid epidemic with Joseph Friedman
Ben Scher talks to Dr Joseph Friedman about his research on fentanyl overdoses. Joseph explains the four waves of opioid overdoses in the US and how opiate and opioid overdoses have changed.They discu...
13 Syys 202315min
Overdose risk, opioid agonists and other medications with Eleni Domzaridou
Rob Calder talks to Dr Eleni Domzaridou about her recent article on the risk of overdose among people prescribe medication for opioid use at the same time as being prescribed other medication - such a...
17 Elo 202318min
Methamphetamine, psychosis and family history with Rebecca McKetin
In this episode Ben Scher talks to Dr Rebecca McKetin about her recent article looking the relationship between psychosis, psychotic symptoms and methamphetamine use. They discuss the implications and...
10 Elo 202318min
Hallucinogen use, young adults and monitoring the future with Katherine Keyes
In this episode, Dr Elle Wadsworth talks to Dr Katherine Keyes about her study examining changes to hallucinogen use among young adults in the US. Katherine also talks about using the Monitoring The F...
3 Elo 202323min
Perspectives on gambling from 1561 with Louise Nadeau
In this episode Ben Scher talks to Professor Louise Nadeau about her recent article anaysing the content of a Latin-language treatise on gambling addiction written nearly 500 years ago. Ben and Louise...
28 Heinä 202323min
Risk of bias in tobacco cessation trials with Jamie Hartmann-Boyce
In this episode, Chloe Burke talks to Dr Jamie Hartmann-Boyce about new guidance from the Cochrane Tobacco Addiction Group (TAG) on assessing and minimising risk of bias in tobacco cessation trials. J...
20 Heinä 202320min
